Insights

Gathering insights about Viridi…

Similar companies to Viridi

Viridi Tech Stack

Viridi uses 8 technology products and services including Google Analytics, Cloudflare, WordPress, and more. Explore Viridi's tech stack below.

Google Analytics
Analytics
Cloudflare
Content Management System
WordPress
Content Management System
Microsoft Word
Editors
Open Graph
Miscellaneous
Yoast SEO
Search Engines
UIKit
UI Frameworks
YouTube
Video Players

Media & News

Viridian Therapeutics, Inc. (VRDN) Reports Q3 Loss, Tops Revenue Estimates
Viridian Therapeutics, Inc. (VRDN) came out with a quarterly loss of $1.15 per share versus the Zacks Consensus Estimate of a loss of $1.11. This compares to loss of $1.09 per share a year ago.
Nov 12, 2024 | www.zacks.com
Viridian Therapeutics' Superior Prospects Make It A Buy
Viridian Therapeutics, Inc.'s VRDN-001, now Veligrotug, shows promising phase 3 data in Thyroid Eye Disease, outperforming Tepezza in early stages and targeting both active and chronic TED. VRDN-001 achieved significant efficacy in the Thrive trial, meeting all primary and secondary endpoints with strong proptosis and diplopia resolution rates, and was well-tolerated. Financially, Viridian has a market cap of $1.87bn and a cash runway of 9–10 quarters, with a potential annual revenue of $8bn if successful.
Oct 23, 2024 | seekingalpha.com
3 Small Biotech Stocks With The 'Big Mo' Right Now
Three small biotech stocks that I have covered lately have shown significant upward movement recently due to positive news. The stocks are experiencing what I call the 'Big Mo,' indicating strong momentum that could lead to additional upward movement. We follow up on these three small biotech/biopharma names and bring followers up to date on the recent positive news flow around them in the paragraphs below.
Sep 19, 2024 | seekingalpha.com
Viridian Therapeutics Announces Pricing of Upsized Public Offering of Shares of Common Stock and Preferred Stock
WALTHAM, Mass.--(BUSINESS WIRE)--Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biotechnology company focused on discovering and developing potential best-in-class medicines for serious and rare diseases, today announced the pricing of an underwritten public offering of shares of its common stock and, in lieu of common stock to certain investors, shares of Series B non-voting convertible preferred stock. Viridian is selling a total of 10,666,600 shares of common stock at a public offering price.
Sep 11, 2024 | www.businesswire.com
VRDN Stock Soars as Eye Disorder Study Meets Primary Endpoints
The phase III THRIVE study evaluating Viridian's veligrotug for treating active thyroid eye disease meets all primary and secondary endpoints.
Sep 11, 2024 | www.zacks.com
Viridian: Active TED Data Signifies Next Round Of Positive Data On The Way
Viridian Therapeutics, Inc. reported that the primary endpoint was met for the phase 3 THRIVE study, using veligrotug for the treatment of patients with active thyroid eye disease. Data release for THRIVE-2 study, using veligrotug for the treatment of patients with chronic thyroid eye disease, expected end of 2024. It is expected that the 7 major thyroid eye disease markets will reach $4.13 billion by 2034.
Sep 10, 2024 | seekingalpha.com
Biotech Stock Scores Big Win, Squeezes Shorts
Viridian Therapeutics Inc (NASDAQ:VRDN) stock is up 11.1% to trade at $15.75 today, and earlier traded as high as $16.35, after the biotech company's eye disorder treatment met the main goal of a late-stage study.
Sep 10, 2024 | www.schaeffersresearch.com

Viridi's Email Address Formats

Viridi uses at least 1 format(s):

Viridi Email Formats	Example	Percentage
FLast@viridiparente.com	JDoe@viridiparente.com	49%
FMLast@viridiparente.com	JMDoe@viridiparente.com	1%
FLast@viridiparente.com	JDoe@viridiparente.com	49%
FMLast@viridiparente.com	JMDoe@viridiparente.com	1%

Frequently Asked Questions

Where is Viridi's headquarters located?

Viridi's main headquarters is located at 1001 East Delavan Buffalo , NY 14215 US. The company has employees across 2 continents, including North AmericaEurope.

What is Viridi's stock symbol?

Viridi is a publicly traded company; the company's stock symbol is VRDN.

What is Viridi's official website and social media links?

Viridi's official website is viridiparente.com and has social profiles on LinkedIn.

How much revenue does Viridi generate?

As of August 2024, Viridi's annual revenue reached $15M.

How many employees does Viridi have currently?

As of August 2024, Viridi has approximately 105 employees across 2 continents, including North AmericaEurope. Key team members include Chief Commercial Officer (cco): W. G.Chief Technology Officer: N. P.Chief Legal Officer: C. K. W.. Explore Viridi's employee directory with LeadIQ.

What industry does Viridi belong to?

Viridi operates in the Manufacturing industry.

What technology does Viridi use?

Viridi's tech stack includes Google AnalyticsCloudflareWordPressMicrosoft WordOpen GraphYoast SEOUIKitYouTube.

What is Viridi's email format?

Viridi's email format typically follows the pattern of . Find more Viridi email formats with LeadIQ.

How much funding has Viridi raised to date?

As of August 2024, Viridi has raised $154M in funding. The last funding round occurred on Jan 04, 2022 for $95M.

When was Viridi founded?

Viridi was founded in 2012.

Viridi

ManufacturingNew York, United States51-200 Employees

Fail-safe lithium-ion battery systems for use in industrial, medical, commercial, municipal and residential buildings.

Company Overview

Headquarters: 1001 East Delavan Buffalo , NY 14215 US
Website: viridiparente.com
Stock Symbol: VRDN
Founded: 2012
Employees: 51-200

Media & News

Funding & Financials

$154M
Viridi has raised a total of $154M of funding over 3 rounds. Their latest funding round was raised on Jan 04, 2022 in the amount of $95Mas a Series C.
$10M$50M
Viridi's revenue is in the range of $10M$50M

Funding & Financials

$154M
Viridi has raised a total of $154M of funding over 3 rounds. Their latest funding round was raised on Jan 04, 2022 in the amount of $95Mas a Series C.
$10M$50M
Viridi's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

Insights

Similar companies to Viridi

EverGreen Solutions

Greenscape

Nature's Pride

Ecolife

Viridi Tech Stack

Media & News

Viridian Therapeutics, Inc. (VRDN) Reports Q3 Loss, Tops Revenue Estimates

Viridian Therapeutics' Superior Prospects Make It A Buy

3 Small Biotech Stocks With The 'Big Mo' Right Now

Viridian Therapeutics Announces Pricing of Upsized Public Offering of Shares of Common Stock and Preferred Stock

VRDN Stock Soars as Eye Disorder Study Meets Primary Endpoints

Viridian: Active TED Data Signifies Next Round Of Positive Data On The Way

Biotech Stock Scores Big Win, Squeezes Shorts

Viridi's Email Address Formats

Frequently Asked Questions

Where is Viridi's headquarters located?

What is Viridi's stock symbol?

What is Viridi's official website and social media links?

How much revenue does Viridi generate?

How many employees does Viridi have currently?

What industry does Viridi belong to?

What technology does Viridi use?

What is Viridi's email format?

How much funding has Viridi raised to date?

When was Viridi founded?

Viridi

Company Overview

Media & News

Viridian Therapeutics, Inc. (VRDN) Reports Q3 Loss, Tops Revenue Estimates

Viridian Therapeutics' Superior Prospects Make It A Buy

3 Small Biotech Stocks With The 'Big Mo' Right Now

Funding & Financials

Funding & Financials

Company Leadership

Employee Directory

Ready to create more pipeline?

Ready to create more pipeline?